Vegetarian Versus Non Vegetarian Based Diet in the Recurrence of Hepatic Encephalopathy in Patients With Cirrhosis: An Open Label Pilot Study
Launched by SIR GANGA RAM HOSPITAL · Mar 17, 2024
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of vegetarian versus non-vegetarian diets on patients who have had a condition called hepatic encephalopathy, which is a complication of liver cirrhosis. The goal is to find out if a plant-based diet can help prevent future episodes of this condition, especially since many patients in India are vegetarian and often lack enough protein in their diets. The study is open to adults aged 18 and older who have a confirmed diagnosis of liver cirrhosis and have recently recovered from a previous episode of hepatic encephalopathy.
Participants in the study can expect to follow a specific diet based on whether they are assigned to the vegetarian or non-vegetarian group. They will be monitored to see how these diets affect their health and recovery. It’s important to note that individuals with severe heart or lung disease, certain liver conditions, or those unwilling to participate in follow-up visits will not be included in the trial. This research could provide valuable insights into dietary choices that may improve the quality of life for patients with liver cirrhosis.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - 1) Age 18 years and older. 2) Confirmed diagnosis of liver cirrhosis. (Diagnosed on the basis of clinical, biochemical, radiological or endoscopic features).
- • 3) Willingness to sign informed consent proforma. 4) Patients who recovered from Hepatic encephalopathy will be enrolled from Out patient Department within 15 days of discharge
- Exclusion Criteria:
- • - 1) Patients with underlying severe cardiopulmonary disease or hepatocellular carcinoma.
- • 2) Patients with CTP score of more than 12 3) Patient not willing for follow up or consent to participate in the study
About Sir Ganga Ram Hospital
Sir Ganga Ram Hospital is a premier multi-specialty healthcare institution located in New Delhi, India, renowned for its commitment to delivering high-quality patient care and advancing medical research. Established in 1954, the hospital is equipped with state-of-the-art facilities and a team of highly skilled professionals dedicated to clinical excellence. As a clinical trial sponsor, Sir Ganga Ram Hospital actively engages in innovative research initiatives aimed at improving treatment outcomes and enhancing patient safety. Through its robust ethical framework and adherence to regulatory standards, the hospital fosters a collaborative environment for clinical research, contributing to the global medical community's efforts in developing effective therapies and interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Delhi, , India
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported